New Report Available: Elekta AB (EKTA B) - Product Pipeline Analysis, 2013 Update

Elekta AB (Elekta) is a medical technology company. The company offers advanced clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. The company classifies its products into four categories, namely, neuroscience, oncology, brachytherapy and software. These products are used in treating cancer with radio therapy and in diagnosing and treating brain disorders in hospitals worldwide. Elekta conducts operations in the regions of North America, Europe, Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.

Elekta continues to view acquisitions as a key part of its growth strategy.

This report is a source for data, analysis and actionable intelligence on the Elekta AB portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Full Report Details at
- http://www.fastmr.com/prod/672684_elekta_ab_ekta_b_product_pipeline_analysis_2013.aspx?afid=301

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
* Design and develop your product development, marketing and sales strategies.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review
- Trinity Biotech Plc (TRIB) - Product Pipeline Analysis, 2013 Update
- Alere Inc. (ALR) - Product Pipeline Analysis, 2013 Update
- B. Braun Melsungen AG - Product Pipeline Analysis, 2013 Update
- Elekta AB (EKTA B) - Medical Equipment - Deals and Alliances Profile